AUSTRIANOVA is a cutting-edge biotech company based in Singapore, specializing in cell encapsulation technology and GMP-grade cell products. The company's expertise and technologies are backed by numerous international peer-reviewed publications and contracts from leading pharmaceutical and biotech companies.

AUSTRIANOVA

Austrianova encapsulates living cells in tiny cellulose beads. The beads act as a microenvironment for living cells, allowing them to be metabolically active and divide, whilst being protected from the environment both in vivo (immunoprotection) and in vitro (sheer force, freezing stress protection). 

Cell-in-a-Box® enables allogenic or xenogenic mammalian cells to be protected from rejection by the immune system, but their porous nature allows therapeutic bioproducts to be released and encapsulated cells to survive for long periods. Cell-in-a-Box® has many advantages e.g. 1) clinically proven safety and efficacy upon implantation of encapsulated cells in patients 2) cells can grow within the capsules in bioreactors and are thus protected from shear forces - especially useful for fragile cells such as stem cells 3) freezing and storage of encapsulated mammalian cells at -80C for more than 5 years and then revival with greater than 90% viability, thus cells can be easily transported on dry ice.

Bac-in-a-Box® enables probiotic bacteria and yeast to be encapsulated to protect them from harsh environments. Bac-in-a-Box® has a number of advantages e.g. 1) it is based on a natural polymer which is digestible 2) it totally protects probiotics from low pH as found in the stomach for extended periods (hours), allowing almost 100% of ingested probiotic cells to reach and be released in the lower intestine 3) it allows freeze drying of probiotics without appreciable loss of viability so they can be easily stored and transported at room temperature.

We offer cell encapsulation R&D and cGMP production for both
 - mammalian cells (stem cells, engineered cell lines etc) all the way from the lab to clinical trial material (Cell-in-a-Box®) and for
- bacteria and yeast encapsulation for excellent long term storage at ambient temperatures as well as 5 to 7 logs better protection from acid degradation in the stomach and later release in the large intestine (Bac-in-a-Box®).

Glocalink Singapore

Real Tech Japan

Ryan Group Holdings

Austrianova

2022 is not quite finished yet but it was a key year for Austrianova with some important goals being reached! We look forward to building on these achievements in 2023. 
 #encapsulation #cellencapsulation #microencapsulation #celltherapy #celltherapymanufacturing #probiotics #microbiome #microbiota #regenerativemedicine 
https://lnkd.in/driCbt6x

Austrianova explains why our Cell-in-a-Box technology is at an advanced stage compared to other cell protection technologies in a news post on the Austrianova website. https://lnkd.in/ds4Yi7Kp #celltherapy  #cellandgenetherapy #encapsulation #microencapsulation #bioencapsulation #clinicaltrials #clinicalstudies #biomanufacturing #gmp #qualitybydesign #cgmp #PMCB #pharmacyte #oncology #pancreaticcancer

WARNING: it has come to our attention that persons unknown are impersonating Austrianova through job interviews and job offers via Austrianova co (not our official address which is Austrianova.com). We are currently NOT hiring and we do NOT conduct any interviews via Telegram or other online services so please disregard any offers or requests. We strongly suggest that you do not provide any personal information to unknown persons.

Attending BIO 2022? Click below to send Austrianova a meeting request in the BIO partnering system! #BIO2022

https://lnkd.in/gF4HXyr6

The Cell-in-a-Box encapsulated cell product CypCaps for pancreatic cancer from PharmaCyte Biotech has just successfully completed a GMP compliant long term storage analysis. The study shows that the product can be stored for at least 2 years frozen without any detrimental effects. #celltherapy #cellandgenetherapy #cellencapsulation #GMP

COM:AUSTRIANOVA

AUSTRIANOVA